Familial combined hyperlipidemiaDisease1 paperTrial sponsorsKuhnil PharmaceuticalCompany1 trialPhase 380 peopleLatestNov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 0Sep 2026: 1Oct 2026: 02 in 12 monthsMethodist DeBakey Cardiovascular Journal·19 SepIs the Commitment to LDL-C Eternal?ReviewIndustry & policyPaperDiagnostics·13 AugDecoding Primary Hyperlipoproteinemias: A Focus on the Pathogenesis and Diagnosis of Familial Hypercholesterolemia and Familial Combined HyperlipidemiaReviewMechanismsPaper
Methodist DeBakey Cardiovascular Journal·19 SepIs the Commitment to LDL-C Eternal?ReviewIndustry & policyPaper
Diagnostics·13 AugDecoding Primary Hyperlipoproteinemias: A Focus on the Pathogenesis and Diagnosis of Familial Hypercholesterolemia and Familial Combined HyperlipidemiaReviewMechanismsPaper